https://doi.org/10.31288/oftalmolzh201744043

Electron microscopy structure of collagen-based corneal substitutes

N.I. Molchaniuk, Cand Sc (Med), O.I. Buznyk, Cand Sc (Med), N.E. Dumbrova, Dr Sc (Med), Prof., N.V. Pasyechnikova, MD, Dr Sc (Med), Prof.

Filatov Institute of Eye Diseases and Tissue Therapy; 

Odessa (Ukraine)

E-mail:  a_buznik@bk.ru             

Purpose: To investigate the electron microscopy structure of biosynthetic corneal substitutes (CS) based on interpenetrating networks of collagen and 2-methacryloyloxyethyl phosphorylcholine (C-MPC).

Materials and Methods: Transmission electron microscopy was used to investigate the structure of C-MPC CS made from 18% solution of recombinant human collagen (RHC) type III  or porcine collagen (PCOL) type I.

Results: Narrow (2-8 nm) collagen-like fibrils with a regular, mainly longitudinal orientation were found in the corneal substitutes. Although the ultrastructure and arrangement of these fibrils were typical for those of human corneal structure, they did not demonstrate some features of the human corneal structure. The fibrils from PCOL-MPC CS  were somewhat wider and less regularly arranged than those from RHC-MPC CS; however, this did not effect the transparency of the implants.

Conclusion: PCOL-MPC implants and RHC-MPC implants have as good optical properties as the human cornea, but their structure and arrangement of filaments are different from those of the human cornea, which may be associated with a very small size of the fibrils produced as a result of collagen molecule cross-linking; that is why they do not scatter light.

Key-words: corneal substitute, donor cornea substitute, collagen, electron microscopy structure         

References

1. Liu Y, Griffith M, Watsky MA, et al. Properties of porcine and recombinant human collagen matrices for optically clear tissue engineering applications. Biomacromolecules. 2006; 7(6):1819–28
   Crossref   Pubmed
2. Liu Y, Gan L, Carlsson DJ, et al. A simple, cross-linked collagen tissue substitute for corneal implantation. Invest Ophthalmol Vis Sci. 2006 May;47(5):1869-75.
   Crossref   Pubmed
3. Fagerholm P, Lagali NS, Merrett K, et al. A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a phase 1 clinical study. Sci Transl Med. 2010 Aug;2(46):46–61
   Crossref   Pubmed
4. Hackett JM, Lagali N, Merrett K et al. Biosynthetic corneal implants for replacement of pathologic corneal tissue: performance in a controlled rabbit alkali burn model. Invest Ophth Vis Sci. 2011 Feb3;52(2):651-7
   Crossref   Pubmed
5. Buznyk O, Pasyechnikova N, Islam MM, Iakymenko S, Fagerholm P, Griffith M. Bioengineered corneas grafted as alternatives to human donor corneas in three high-risk patients. Clin Transl Sci. 2015 Oct;8(5):558-62
   Crossref   Pubmed
6. Reynolds E. S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol. 1963 Apr;17:208-12
   Crossref   Pubmed
7. Vit VV. [The structure of the human visual system] Odessa: Astroprint; 2003.
8. Hayes S, Lewis P, Islam MM, et al. The structural and optical properties of type III human collagen biosynthetic corneal substitutes. Acta Biomater. 2015 Oct;25:121-30
   Crossref   Pubmed